Emergency ambulatory outpatient management of immune-mediated hypophysitis
暂无分享,去创建一个
P. Lorigan | T. Cooksley | T. Knight | Avinash Gupta | S. Adam | C. Higham | Safwaan Adam
[1] P. Lorigan,et al. Emergency presentations in patients treated with immune checkpoint inhibitors. , 2020, European journal of cancer.
[2] D. Lasserson,et al. Ambulatory emergency oncology: A key tenet of future emergency oncology care , 2020, International journal of clinical practice.
[3] F. Hodi,et al. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. , 2018, Endocrine reviews.
[4] R. Sullivan,et al. High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma , 2018, Cancer.
[5] D. Lasserson,et al. What is the evidence base for ambulatory care for acute medical illness? , 2018, Acute medicine.
[6] M. Atkins,et al. The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management , 2018, JNCI cancer spectrum.
[7] J. Larkin,et al. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy , 2018, Endocrine connections.
[8] T. Cooksley,et al. Acute Oncology Care: A narrative review of the acute management of neutropenic sepsis and immune-related toxicities of checkpoint inhibitors. , 2017, European journal of internal medicine.
[9] D. Kyriacou,et al. Trends in Adult Cancer–Related Emergency Department Utilization: An Analysis of Data From the Nationwide Emergency Department Sample , 2017, JAMA oncology.
[10] K. Kerr,et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] K. Kerr,et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] Charles R. Thomas,et al. An Inflection Point in the Evolution of Oncologic Emergency Medicine. , 2016, Annals of emergency medicine.
[13] P. Chanson,et al. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] T. Cooksley,et al. Emergency oncology: development, current position and future direction in the USA and UK , 2016, Supportive Care in Cancer.